SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001892
Filing Date
2023-08-14
Accepted
2023-08-14 16:31:00
Documents
73
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rnaz-20230630x10q.htm   iXBRL 10-Q 1156999
2 EX-1.1 rnaz-20230630xex1d1.htm EX-1.1 16061
3 EX-31.1 rnaz-20230630xex31d1.htm EX-31.1 9804
4 EX-31.2 rnaz-20230630xex31d2.htm EX-31.2 10686
5 EX-32.1 rnaz-20230630xex32d1.htm EX-32.1 8896
6 EX-32.2 rnaz-20230630xex32d2.htm EX-32.2 7924
  Complete submission text file 0001410578-23-001892.txt   5524840

Data Files

Seq Description Document Type Size
7 EX-101.SCH rnaz-20230630.xsd EX-101.SCH 53172
8 EX-101.CAL rnaz-20230630_cal.xml EX-101.CAL 35564
9 EX-101.DEF rnaz-20230630_def.xml EX-101.DEF 131220
10 EX-101.LAB rnaz-20230630_lab.xml EX-101.LAB 409441
11 EX-101.PRE rnaz-20230630_pre.xml EX-101.PRE 297095
67 EXTRACTED XBRL INSTANCE DOCUMENT rnaz-20230630x10q_htm.xml XML 761907
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40363 | Film No.: 231170968
SIC: 2834 Pharmaceutical Preparations